Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $8,623 | 4 | 56.6% |
| Food and Beverage | $3,667 | 114 | 24.0% |
| Travel and Lodging | $1,780 | 12 | 11.7% |
| Consulting Fee | $1,170 | 1 | 7.7% |
| Education | $7.86 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $9,766 | 40 | $0 (2024) |
| Covidien LP | $2,166 | 21 | $0 (2019) |
| Janssen Biotech, Inc. | $1,295 | 2 | $0 (2018) |
| ABBVIE INC. | $608.66 | 23 | $0 (2024) |
| GENZYME CORPORATION | $242.93 | 7 | $0 (2024) |
| Cook Medical LLC | $231.25 | 4 | $0 (2024) |
| Celgene Corporation | $230.07 | 10 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $217.52 | 10 | $0 (2024) |
| Prometheus Laboratories Inc. | $99.43 | 1 | $0 (2017) |
| Olympus America Inc. | $88.75 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,051 | 41 | ABBVIE INC. ($380.07) |
| 2023 | $557.13 | 20 | Cook Medical LLC ($131.00) |
| 2022 | $65.46 | 2 | GENZYME CORPORATION ($65.46) |
| 2021 | $140.90 | 3 | AbbVie Inc. ($98.00) |
| 2020 | $2,829 | 7 | PFIZER INC. ($2,809) |
| 2019 | $7,831 | 44 | PFIZER INC. ($6,784) |
| 2018 | $2,654 | 13 | Janssen Biotech, Inc. ($1,295) |
| 2017 | $119.85 | 2 | Prometheus Laboratories Inc. ($99.43) |
All Payment Transactions
132 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/12/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $37.88 | General |
| Category: Immunology | ||||||
| 09/17/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: IMMUNOLOGY | ||||||
| 09/17/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $12.18 | General |
| Category: IMMUNOLOGY | ||||||
| 09/11/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 09/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $30.66 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/03/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: IMMUNOLOGY | ||||||
| 08/29/2024 | Olympus America Inc. | DISPOSABLE BIOPSY FORCEPS (Device) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: Endotherapy | ||||||
| 08/20/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $31.74 | General |
| Category: IMMUNOLOGY | ||||||
| 08/08/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $33.56 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/06/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $25.91 | General |
| Category: IMMUNOLOGY | ||||||
| 08/06/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $25.81 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/22/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 07/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $43.22 | General |
| Category: Immunology | ||||||
| 07/17/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $21.68 | General |
| Category: Neuroscience | ||||||
| 07/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $25.60 | General |
| Category: INTERNAL MEDICINE | ||||||
| 07/15/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $27.68 | General |
| Category: Oncology | ||||||
| 06/28/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $28.00 | General |
| Category: IMMUNOLOGY | ||||||
| 06/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.85 | General |
| Category: IMMUNOLOGY | ||||||
| 06/12/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 05/28/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: IMMUNOLOGY | ||||||
| 05/23/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $26.91 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/15/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 376 | 455 | $189,842 | $40,848 |
| 2022 | 9 | 205 | 212 | $102,096 | $19,898 |
| 2021 | 8 | 247 | 285 | $95,197 | $26,192 |
| 2020 | 5 | 128 | 151 | $45,730 | $10,558 |
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 60 | 60 | $46,440 | $12,493 | 26.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 48 | 101 | $19,998 | $6,516 | 32.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 67 | 90 | $22,410 | $6,405 | 28.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 74 | 74 | $51,208 | $5,375 | 10.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 37 | 38 | $12,844 | $3,872 | 30.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 49 | 49 | $25,627 | $3,338 | 13.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 13 | 15 | $5,535 | $1,416 | 25.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 16 | 16 | $5,456 | $1,386 | 25.4% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2023 | 12 | 12 | $324.00 | $45.80 | 14.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 30 | 30 | $23,220 | $5,799 | 25.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 52 | 53 | $36,676 | $4,387 | 12.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 26 | 28 | $6,972 | $2,050 | 29.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 17 | 17 | $5,746 | $1,760 | 30.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 25 | 26 | $13,598 | $1,633 | 12.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 16 | 16 | $5,456 | $1,507 | 27.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 14 | 16 | $5,904 | $1,437 | 24.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 13 | 13 | $2,327 | $768.74 | 33.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 12 | 13 | $2,197 | $556.72 | 25.3% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 40 | 40 | $23,200 | $7,562 | 32.6% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 66 | 66 | $32,274 | $5,398 | 16.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 33 | 47 | $9,071 | $3,311 | 36.5% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 40 | 40 | $12,440 | $3,016 | 24.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 14 | 24 | $4,632 | $1,852 | 40.0% |
| 45378 | Diagnostic examination of the colon (large bowel) using an endoscope(colonoscopy); high risk | Facility | 2021 | 11 | 11 | $4,543 | $1,516 | 33.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 14 | 23 | $3,473 | $1,335 | 38.4% |
About Dr. Daniel Chan, MD
Dr. Daniel Chan, MD is a Gastroenterology healthcare provider based in Ewa Beach, Hawaii. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/21/2011. The National Provider Identifier (NPI) number assigned to this provider is 1255627980.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Chan, MD has received a total of $15,248 in payments from pharmaceutical and medical device companies, with $1,051 received in 2024. These payments were reported across 132 transactions from 18 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($8,623).
As a Medicare-enrolled provider, Chan has provided services to 956 Medicare beneficiaries, totaling 1,103 services with total Medicare billing of $97,496. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Ewa Beach, HI
- Active Since 06/21/2011
- Last Updated 08/05/2021
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1255627980
Products in Payments
- COLOGUARD (Device) $9,364
- STELARA (Biological) $1,295
- PillCam (Device) $807.51
- RINVOQ (Biological) $399.33
- XELJANZ (Drug) $386.20
- DUPIXENT (Biological) $286.31
- ZEPOSIA (Drug) $230.07
- SKYRIZI (Biological) $163.96
- ENTYVIO (Biological) $133.75
- Manometry (Device) $109.91
- SAEED (Device) $104.71
- HEMOSPRAY (Device) $95.72
- ELEVIEW (Device) $81.66
- Entyvio (Biological) $67.22
- IBSRELA (Drug) $60.47
- ManoScan (Device) $52.37
- OMVOH (Drug) $33.77
- FUSION (Device) $30.82
- Cologuard Collection Kit (Device) $27.68
- CREON (Drug) $25.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.